MAP2K7 and cancer: This is highly significant as oncogenic RAS (active in approximately 30% of all human cancers) signals partly via MEK/ERK (Schubbert et al, 2007), thus further investigation of NFAT signalling in the context of oncogenic Ras/RAF is merited.